Trevi Therapeutics Inc (TRVI)
2.83
+0.06
(+2.17%)
USD |
NASDAQ |
May 20, 16:00
2.83
0.00 (0.00%)
After-Hours: 20:00
Trevi Therapeutics Total Liabilities (Quarterly): 6.225M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 6.225M |
December 31, 2023 | 6.856M |
September 30, 2023 | 6.286M |
June 30, 2023 | 5.904M |
March 31, 2023 | 14.47M |
December 31, 2022 | 15.56M |
September 30, 2022 | 18.46M |
June 30, 2022 | 20.90M |
March 31, 2022 | 19.92M |
December 31, 2021 | 21.40M |
September 30, 2021 | 20.22M |
Date | Value |
---|---|
June 30, 2021 | 21.41M |
March 31, 2021 | 19.18M |
December 31, 2020 | 19.85M |
September 30, 2020 | 20.26M |
June 30, 2020 | 6.972M |
March 31, 2020 | 7.436M |
December 31, 2019 | 5.456M |
September 30, 2019 | 5.313M |
June 30, 2019 | 7.413M |
March 31, 2019 | 4.51M |
December 31, 2018 | 4.278M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.313M
Minimum
Sep 2019
21.41M
Maximum
Jun 2021
13.47M
Average
15.01M
Median
Total Liabilities (Quarterly) Benchmarks
Accuray Inc | 421.45M |
Vanda Pharmaceuticals Inc | 108.69M |
NovaBay Pharmaceuticals Inc | 5.197M |
Palatin Technologies Inc | 9.827M |
iBio Inc | 25.29M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 78.56M |
Shareholders Equity (Quarterly) | 72.33M |